Heartflow

Heartflow EBITDA Margin

The EBITDA Margin of Heartflow (HTFL) as of Nov 11, 2026 is -36.39 %. In the previous year, EBITDA Margin was -58.51 % — a change of -37.79% (higher).

EBITDA Margin

-36.39 %

YoY

-37.79%

Last updated:

EBITDA Margin of Heartflow is 2025 -36.39 % . EBITDA Margin of Heartflow was 2024 -58.51 % . It decreases by -37.79% higher compared to the previous year.

The Heartflow EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2023
-87.03 USD
Jan 1, 2024
-58.51 USD
Jan 1, 2025
-36.39 USD
The Heartflow EBITDA Margin history
YEAREBITDA MarginYoY
-36.39 %-37.79%
-58.51 %-32.78%
-87.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heartflow Stock analysis

What does Heartflow do? Heartflow Inc generates revenue through its HeartFlow Platform, which includes AI-driven software solutions for diagnosing coronary artery disease. The company's products, such as HeartFlow FFRCT Analysis and Plaque Analysis, assist physicians in managing patient care by providing personalized 3D heart models derived from CCTA scans. These tools are sold to healthcare providers and hospitals, enabling non-invasive diagnosis and treatment planning for coronary artery disease. The RoadMap Analysis offers intuitive visualization of coronary arteries, helping physicians focus on critical areas during patient reviews. The HeartFlow Platform leverages artificial intelligence and computational fluid dynamics to create detailed cardiac models, positioning Heartflow Inc as a leader in medical technology for cardiovascular diagnostics. Its commercial-stage operations focus on delivering precision care solutions that improve diagnostic accuracy and patient outcomes. Healthcare institutions purchase these AI-powered tools to enhance their diagnostic capabilities without invasive procedures. Heartflow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heartflow stock

EBITDA Margin of Heartflow is -36.39 % in 2025.

EBITDA Margin of Heartflow changed from -58.51 % to -36.39 %, representing a -37.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Heartflow since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Heartflow with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Heartflow

All Key Metrics — Heartflow